MediSense preparing for launch of Precision QID third-generation blood glucose monitor.
This article was originally published in The Tan Sheet
Executive Summary
MEDISENSE PRECISION QID THIRD-GENERATION GLUCOSE MONITORING SYSTEM will begin U.S. shipments "at or around the end of this quarter," MediSense Chairman and CEO Robert Coleman, PhD, said at a May 16 session of the Alex. Brown & Sons health care seminar in Baltimore. Both the home glucose monitoring device and attendant disposable strips were cleared for marketing by FDA on March 23.